Overview of our Corporate News

September 27, 2018

Micro pump for Parkinson’s treatment from Gerresheimer subsidiary Sensile Medical receives European CE declaration of conformity

Duesseldorf/Olten, September 27, 2018 – A wearable micro pump from Sensile Medical has received EU certification for the European market. A European pharma...

September 06, 2018

Dietmar Siemssen appointed new CEO of Gerresheimer AG

Dietmar Siemssen to assume as Chief Executive Officer on November 1, 2018. Previously held position as Stabilus CEO. Speaker of the Management Board and CFO...

July 11, 2018

Ad Hoc: Gerresheimer acquires Sensile Medical / irrespective of that, increased growth and improved profitability expected mid-term due to two new major orders with temporarily higher capex / organic revenue guidance 2018 narrowed to upper end of range

July 11, 2018

Gerresheimer extends business model and increases growth forecast

With the acquisition of Sensile Medical, Gerresheimer is extending its business model in the direction of an Original Equipment Manufacturer (OEM) for drug...

April 25, 2018

Annual General Meeting of Gerresheimer AG approves dividend increase to EUR 1.10 per share

Duesseldorf, April 25, 2018 – The distribution of a dividend of EUR 1.10 per share was approved at the Annual General Meeting of Gerresheimer AG held today in...